Vaccine Development for Neglected Tropical Diseases

Neglected tropical diseases (NTDs) remain a significant public health challenge, disproportionately affecting impoverished populations in tropical and subtropical regions. Despite substantial progress in combating certain infectious diseases, vaccine development for NTDs has lagged due to economic, scientific, and logistical barriers. Recent advancements in biotechnology, such as mRNA vaccines and omics technologies, offer new opportunities to accelerate vaccine discovery and development for NTDs. This review examines the current state of vaccine development for major NTDs, including Chagas disease, leishmaniasis, and schistosomiasis. We discuss the challenges involved in developing vaccines for these diseases, the role of public-private partnerships, and innovative approaches to enhance vaccine access and efficacy. Moreover, this review highlights the importance of global initiatives and funding mechanisms such as the London Declaration on NTDs, which emphasize international collaboration to end the neglect of these diseases. The aim of this work is to provide a comprehensive overview of the scientific and economic strategies needed to advance vaccine development and access for NTDs, ultimately reducing their global burden.